Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | Niemann-Pick disease, type C1 | Starlite/ChEMBL | No references |
Homo sapiens | synuclein, alpha (non A4 component of amyloid precursor) | Starlite/ChEMBL | No references |
Homo sapiens | glycoprotein hormones, alpha polypeptide | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Toxoplasma gondii | intraflagellar transport protein 172, putative | glycoprotein hormones, alpha polypeptide | 116 aa | 94 aa | 26.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Niemann-Pick C1 protein precursor | 0.0119 | 0.5432 | 1 |
Echinococcus multilocularis | Niemann Pick C1 protein | 0.017 | 1 | 1 |
Echinococcus multilocularis | Niemann Pick C1 protein | 0.0119 | 0.5432 | 0.5432 |
Schistosoma mansoni | niemann-pick C1 (NPC1) | 0.0121 | 0.5596 | 1 |
Echinococcus granulosus | Niemann Pick C1 protein | 0.0119 | 0.5432 | 0.1238 |
Loa Loa (eye worm) | acetylcholinesterase 1 | 0.0114 | 0.5008 | 0.9194 |
Echinococcus multilocularis | acetylcholinesterase | 0.0114 | 0.5008 | 0.5008 |
Brugia malayi | Carboxylesterase family protein | 0.0114 | 0.5008 | 0.9194 |
Echinococcus multilocularis | carboxylesterase 5A | 0.0114 | 0.5008 | 0.5008 |
Echinococcus granulosus | carboxylesterase 5A | 0.0114 | 0.5008 | 0.0426 |
Brugia malayi | Carboxylesterase family protein | 0.0114 | 0.5008 | 0.9194 |
Loa Loa (eye worm) | hypothetical protein | 0.0114 | 0.5008 | 0.9194 |
Echinococcus multilocularis | acetylcholinesterase | 0.0114 | 0.5008 | 0.5008 |
Loa Loa (eye worm) | hypothetical protein | 0.0062 | 0.0382 | 0.0392 |
Entamoeba histolytica | Niemann-Pick C1 protein, putative | 0.0119 | 0.5432 | 0.5 |
Loa Loa (eye worm) | carboxylesterase | 0.0114 | 0.5008 | 0.9194 |
Echinococcus granulosus | acetylcholinesterase | 0.0114 | 0.5008 | 0.0426 |
Echinococcus multilocularis | expressed conserved protein | 0.0112 | 0.4786 | 0.4786 |
Echinococcus granulosus | acetylcholinesterase | 0.0114 | 0.5008 | 0.0426 |
Loa Loa (eye worm) | hypothetical protein | 0.0119 | 0.5432 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0114 | 0.5008 | 0.9194 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 0.5012 um | PUBCHEM_BIOASSAY: qHTS Assay for NPC1 Promoter Activators. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 0.7943 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 2.8184 uM | PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 3.5481 uM | PubChem BioAssay. qHTS of alpha-syn Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PubChem BioAssay. qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.